HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 293/1/C12    most recent 00314.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Scatena, R. Articles by Giardina, B. Search for Related Content PubMed PubMed Citation Articles by Scatena, R. Articles by Giardina, B.

SPECIAL SECTION ON MITOCHONDRIAL MODELING AND FUNCTION

The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic

¹Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, Rome; and ²Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Siena, Italy

In addition to their well-known critical role in energy metabolism, mitochondria are now recognized as the location where various catabolic and anabolic processes, calcium fluxes, various oxygen-nitrogen reactive species, and other signal transduction pathways interact to maintain cell homeostasis and to mediate cellular responses to different stimuli. It is important to consider how pharmacological agents affect mitochondrial biochemistry, not only because of toxicological concerns but also because of potential therapeutic applications. Several potential targets could be envisaged at the mitochondrial level that may underlie the toxic effects of some drugs. Recently, antiviral nucleoside analogs have displayed mitochondrial toxicity through the inhibition of DNA polymerase- (pol-). Other drugs that target different components of mitochondrial channels can disrupt ion homeostasis or interfere with the mitochondrial permeability transition pore. Many known inhibitors of the mitochondrial electron transfer chain act by interfering with one or more of the respiratory chain complexes. Nonsteroidal anti-inflammatory drugs (NSAIDs), for example, may behave as oxidative phosphorylation uncouplers. The mitochondrial toxicity of other drugs seems to depend on free radical production, although the mechanisms have not yet been clarified. Meanwhile, drugs targeting mitochondria have been used to treat mitochondrial dysfunctions. Importantly, drugs that target the mitochondria of cancer cells have been developed recently; such drugs can trigger apoptosis or necrosis of the cancer cells. Thus the aim of this review is to highlight the role of mitochondria in pharmacotoxicology, and to describe whenever possible the main molecular mechanisms underlying unwanted and/or therapeutic effects.

mitochondrial diseases; nitric oxide; apoptosis; degenerative diseases; free radicals

This article has been cited by other articles:

				F. Pomati, C. Orlandi, M. Clerici, F. Luciani, and E. Zuccato Effects and Interactions in an Environmentally Relevant Mixture of Pharmaceuticals Toxicol. Sci., March 1, 2008; 102(1): 129 - 137. [Abstract] [Full Text] [PDF]